Abstract:The virion infectivity factor (Vif) open reading frame is conserved among most lentiviruses. Vif molecules contribute to viral replication by inactivating host antiviral factors, the APOBEC3 cytidine deaminases. However, various species of lentiviral Vif proteins have evolved different strategies for overcoming host APOBEC3. Whether different species of lentiviral Vif proteins still preserve certain common features has not been reported. Here, we show for the first time that diverse lentiviral Vif molecules maintain the ability to interact with the human immunodeficiency virus type 1 (HIV-1) Gag precursor (Pr55(Gag)) polyprotein. Surprisingly, bovine immunodeficiency virus (BIV) Vif, but not HIV-1 Vif, interfered with HIV-1 production and viral infectivity even in the absence of APOBEC3. Further analysis revealed that BIV Vif demonstrated an enhanced interaction with Pr55(Gag) compared to that of HIV-1 Vif, and BIV Vif defective for the Pr55(Gag) interaction lost its ability to inhibit HIV-1. The C-terminal region of capsid (CA) and the p2 region of Pr55(Gag), which are important for virus assembly and maturation, were involved in the interaction. Transduction of CD4(+) T cells with BIV Vif blocked HIV-1 replication. Thus, the conserved VifPr55(Gag) interaction provides a potential target for the future development of antiviral strategies. IMPORTANCE The conserved Vif accessory proteins of primate lentiviruses HIV-1, simian immunodeficiency virus (SIV), and BIV all form ubiquitin ligase complexes to target host antiviral APOBEC3 proteins for degradation, with different cellular requirements and using different molecular mechanisms. Here, we demonstrate that BIV Vif can interfere with HIV-1 Gag maturation and suppress HIV-1 replication through interaction with the precursor of the Gag (Pr55(Gag)) of HIV-1 in virusproducing cells. Moreover, the HIV-1 and SIV Vif proteins are conserved in terms of their interactions with HIV-1 Pr55(Gag) although HIV-1 Vif proteins bind Pr55(Gag) less efficiently than those of BIV Vif. Our research not only sheds new light on this feature of these conserved lentiviral Vif proteins but also provides a formerly unrecognized target for the development of antiviral strategies. Since increasing the VifPr55(Gag) interaction could potentially suppress virus proliferation, this approach could offer a new strategy for the development of HIV inhibitors.

The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells.

The Vif Accessory Protein Alters the Cell Cycle of Human Immunodeficiency Virus Type 1 Infected Cells (45.15)

HIV-1 Vif promotes the G1- to S-phase cell-cycle transition

The Hiv-1 Vif Protein Mediates Degradation Of Vpr And Reduces Vpr-Induced Cell Cycle Arrest

HIV-1 Vif disrupts phosphatase feedback regulation at the kinetochore, leading to a pronounced pseudo-metaphase arrest

Vif-CBFβ Interaction is Essential for Vif-induced Cell Cycle Arrest.

The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes

The structure and function of HIV-1 accessory protein Vif

Evolutionarily Conserved Pressure for the Existence of Distinct G2/M Cell Cycle Arrest and A3H Inactivation Functions in HIV-1 Vif.

[Progress in the Study of HIV-1 Vif and Related Inhibitors].

Genetic Variance in the HIV-1 Founder Virus Vpr Affects Its Ability to Induce Cell Cycle G₂arrest and Cell Apoptosis.

Association of Human Immunodeficiency Virus Type 1 Vif with RNA and Its Role in Reverse Transcription.

HIV-1 Vpr causes separate cell cycle arrests in G2 and M that activate alternative DNA damage pathways

A Naturally Occurring Vif Mutant (I107T) Attenuates Anti-Apobec3g Activity and HIV-1 Replication.

Conserved interaction of lentiviral Vif molecules with HIV-1 Gag and differential effects of species-specific Vif on virus production.

Modeling the Intracellular Dynamics for Vif-APO Mediated HIV-1 Virus Infection

Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.

Three-dimensional Structure of HIV-1 VIF Constructed by Comparative Modeling and the Function Characterization Analyzed by Molecular Dynamics Simulation

HIV-1 Vpr Protein Activates the NF-κB Pathway to Promote G2/M Cell Cycle Arrest

HIV-1 Vpr Functions in Primary CD4+ T Cells

HIV-1 Vif Suppresses Antiviral Immunity by Targeting STING